Mosquito-Borne Infections Testing Market Growth To $2.12 Billion Creates New Opportunities Across The Industry
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Mosquito-Borne Infections Testing Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The mosquito-borne infections testing market has experienced robust expansion in recent years. Its valuation is projected to rise from $1.44 billion in 2025 to $1.56 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.8%. This historical growth can be linked to factors such as the increasing occurrence of dengue and malaria outbreaks, restricted availability of advanced diagnostic facilities in developing areas, heightened understanding of the burden of vector-borne diseases, increased laboratory testing capabilities within urban healthcare systems, and a rise in government financial support for initiatives aimed at controlling infectious diseases.
The mosquito-borne infections testing market is projected to experience substantial expansion over the upcoming years, reaching a valuation of $2.12 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.0%. This anticipated growth is primarily driven by factors such as the spread of mosquito habitats and disease zones due to climate change, the increasing integration of rapid molecular diagnostic technologies, advancements in real-time outbreak surveillance, a growing need for integrated public health data systems, and the development of personalized and precise infectious disease diagnostics. Key developments expected during this period include a surge in demand for swift diagnostic testing due to more frequent mosquito-borne outbreaks, the proliferation of decentralized and point-of-care testing in remote areas, greater use of multiplex assays for detecting multiple vector-borne pathogens concurrently, an increase in government-led surveillance and screening initiatives for early outbreak detection, and a rising preference for mobile and deployable diagnostic kits to accelerate epidemic responses.
Get A Free Sample Report With In-Depth Market Insights:
Mosquito-Borne Infections Testing Market Growth Backed By Core Demand Fundamentals
The increasing occurrence of dengue illnesses is anticipated to boost the expansion of the Mosquito Borne Infections Testing market in the future. Dengue is a viral infection primarily transmitted by aedes mosquitoes carrying the dengue virus. The frequency of dengue cases is growing, attributed to elevated temperatures and heavier rainfall that foster suitable breeding environments for aedes mosquitoes, alongside rapid urban development leading to greater human contact with mosquito populations. Testing for mosquito-borne infections aids in the prompt identification and ongoing surveillance of dengue infections through detecting the virus in individuals, facilitating early medical care and public health initiatives to curb its dissemination. For example, data from July 2023, provided by the Switzerland-based intergovernmental organization, the World Health Organization, revealed that Brazil reported 2,376,522 dengue cases by epidemiological week 26; of these, 1,051,773 (44.2%) were confirmed by laboratory tests, and 1,249 (0.05%) were identified as severe dengue, indicating a 13% rise from the corresponding period in 2022. Consequently, the escalating prevalence of dengue diseases is fueling the expansion of the mosquito borne infections testing market.
Mosquito-Borne Infections Testing Market Segment Outlook: Which Categories Are Growing Fastest?
The mosquito-borne infections testing market covered in this report is segmented –
1) By Test Type: Molecular Diagnostic Tests, Serological Tests, Rapid Antigen Tests, Polymerase Chain Reaction (PCR) Testing Services, Laboratory Reagent-Based Tests
2) By Sample Type: Blood Samples, Serum Samples, Plasma Samples, Urine Samples, Saliva Samples
3) By Infection Type: Dengue, Malaria, Zika Virus, Chikungunya, West Nile Virus, Other Infection Types
4) By Technology: Enzyme-Linked Immunosorbent Assay, Lateral Flow Assay, Polymerase Chain Reaction, Next-Generation Sequencing, Other Technologies
5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Public Health Agencies, Research Institutes, Point-Of-Care Settings
Subsegments:
1) By Molecular Diagnostic Tests: Nucleic Acid Amplification Testing, Reverse Transcription Polymerase Chain Reaction Testing, Multiplex Molecular Testing, Isothermal Amplification Testing, Pathogen Specific Genetic Testing
2) By Serological Tests: Immunoglobulin M Antibody Testing, Immunoglobulin G Antibody Testing, Antigen Detection Testing, Neutralization Assays, Enzyme Immunoassay Testing
3) By Rapid Antigen Tests: Point Of Care Antigen Testing, Lateral Flow Antigen Testing, Immunochromatographic Antigen Testing, Portable Rapid Diagnostic Testing, Field Based Antigen Testing
4) By Polymerase Chain Reaction Testing Services: Real Time Polymerase Chain Reaction Testing, Quantitative Polymerase Chain Reaction Testing, Multiplex Polymerase Chain Reaction Testing, Digital Polymerase Chain Reaction Testing, Reverse Transcription Polymerase Chain Reaction Testing
5) By Laboratory Reagent Based Tests: Reagent Kit Based Diagnostic Testing, Chemical Reaction Based Testing, Enzyme Reagent Testing, Staining Reagent Testing, Buffer Solution Based Testing
Mosquito-Borne Infections Testing Market Growth Trends Reshaping The Competitive Landscape
Leading firms within the mosquito-borne infections testing market are prioritizing the creation of novel approaches, such as automated high-throughput immunoassays, aiming to provide swifter, more precise, and scalable identification of mosquito-borne pathogens. These advanced laboratory tests function by automatically identifying specific antigens or antibodies across a multitude of samples, thus facilitating a rapid, accurate, and scalable diagnosis of mosquito-borne infections, presenting a significant advantage over conventional manual methods. Illustratively, in October 2025, the Swiss biotechnology and diagnostics firm, F. Hoffmann-La Roche Ltd., secured CE mark approval for its Elecsys Dengue Ag test, an inventive automated immunoassay specifically engineered to detect the NS1 antigen of the dengue virus within human serum and plasma. Operating on Roche’s fully automated cobas e analysers, this test delivers results in a mere 18 minutes and consistently identifies all four dengue virus serotypes. Its prominent attributes encompass high clinical sensitivity and specificity, a medium-to-high throughput ranging from 120 to 300 tests per hour, improved traceability, and streamlined workflow efficiency, proving especially valuable during dengue outbreaks for prompt patient management and surveillance. Ultimately, the Elecsys Dengue Ag test marks a substantial stride forward from traditional methodologies, offering consistent, swift, and comprehensive diagnostic capabilities throughout the complete patient care continuum.
Mosquito-Borne Infections Testing Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the mosquito-borne infections testing market are F. Hoffmann-La Roche Ltd, Trinity Biotech plc, Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings (LabCorp), Grifols S. A., Hologic Inc., bioMérieux SA, Bio-Rad Laboratories Inc., QIAGEN N. V., DiaSorin S. p. A., Euroimmun Medizinische Diagnostika AG, SD Biosensor Inc., Promega Corporation, Mayo Clinic Laboratories, Meridian Bioscience Inc., R-Biopharm AG, Boditech Med Inc., NanoEntek Inc., Entomogen Inc., J. Mitra and Co. Pvt. Ltd., Today’s Clinical Lab Pvt. Ltd., Co-Dx Inc.
View The Full Mosquito-Borne Infections Testing Market Report:
Mosquito-Borne Infections Testing Market Regional Outlook: Where Is Opportunity Concentrated?
Asia-Pacific was the largest region in the mosquito-borne infections testing market in 2025. Latin America is expected to be the fastest-growing region in the forecast period. The regions covered in the mosquito-borne infections testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
